0001209191-18-059044.txt : 20181116 0001209191-18-059044.hdr.sgml : 20181116 20181116175638 ACCESSION NUMBER: 0001209191-18-059044 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181116 FILED AS OF DATE: 20181116 DATE AS OF CHANGE: 20181116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Levy Howard CENTRAL INDEX KEY: 0001672333 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51173 FILM NUMBER: 181190867 MAIL ADDRESS: STREET 1: 260 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001124105 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562020050 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 260 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6507450655 MAIL ADDRESS: STREET 1: 260 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: TARGACEPT INC DATE OF NAME CHANGE: 20000919 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-11-16 0 0001124105 CATALYST BIOSCIENCES, INC. CBIO 0001672333 Levy Howard 611 GATEWAY BOULEVARD, SUITE 710 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Medical Officer Common Stock 2018-11-16 4 M 0 173 4.63 A 7733 D Common Stock 2018-11-16 4 S 0 173 11.00 D 7560 D Stock Option (Right to Buy) 4.63 2018-11-16 4 M 0 173 0.00 D 2027-07-11 Common Stock 173 87267 D Sale of shares made pursuant to and in accordance with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, under a plan adopted by the Reporting Person on September 5, 2018. The Option vests monthly over a period of four years commencing June 15, 2017. /s/ Faisal Shawwa Attorney-in-Fact for Howard Levy 2018-11-16